Dr. Krishnalatha Sreekrishnanilayam Devakliamma, MD

Dr. Sreekrishnanilayam Devakliamma practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Sreekrishnanilayam Devakliamma's NPI, 1396177143, was assigned on August 4, 2013. Dr. Sreekrishnanilayam Devakliamma holds Pennsylvania license MD459268.

Dr. Sreekrishnanilayam Devakliamma's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Sreekrishnanilayam Devakliamma's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Sreekrishnanilayam Devakliamma is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Sreekrishnanilayam Devakliamma to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sreekrishnanilayam Devakliamma practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sreekrishnanilayam Devakliamma's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sreekrishnanilayam Devakliamma is licensed in Pennsylvania.

CMS data shows 598 Medicare services from Dr. Sreekrishnanilayam Devakliamma across 6 procedure codes in 2024, for 134 Medicare patients. Medicare paid $43,650 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Sreekrishnanilayam Devakliamma in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have cancer, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sreekrishnanilayam Devakliamma's median patient age at 71, with 33% women.

In 2024, Dr. Sreekrishnanilayam Devakliamma wrote 222 Medicare Part D claims for 80 patients. 90% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $118 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Sreekrishnanilayam Devakliamma for performance year 2024, reported as part of a group. Dr. Sreekrishnanilayam Devakliamma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Sreekrishnanilayam Devakliamma from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Alnylam Pharmaceuticals Inc. paid the most, $26.